BiotechTube
Home/Antagonis Biotherapeutics/Andreas J. Kungl
AJ

Andreas J. Kungl

Founder, Scientific Director/CEO

Antagonis Biotherapeutics

Therapeutic Areas

OncologyImmuno-oncology

Antagonis Biotherapeutics Pipeline

DrugIndicationPhase
MCP-1-based GAGbody™Cancer MetastasisPre-clinical

Leadership Team at Antagonis Biotherapeutics

FS
Frank S. Walsh
Management Board
View full Antagonis Biotherapeutics profile